Corporate Forum Blog

The Corporate Forum is delighted to introduce Verastem, Inc. to an audience of Boston retail investors. 

Located in Cambridge, MA, Verastem is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells along with companion diagnostics. 

The company’s product candidates target CSCs that have been implicated in aggressive cancers, metastasis, and chemotherapeutic resistance. The company is listed on NASDAQ with sufficient capital to late 2015/early 2016 with a potential registration study slated for midyear 2013.

The company is backed by research from the Whitehead and Broad Institutes of MIT and Harvard. Scientific cofounder and chair of the scientific advisory board, Robert Weinberg, PhD, is widely considered the father of the genetic basis of cancer.

The management team includes Chairman/CEO Christoph Westphal, MD, PhD, (founder/CEO of VSTM, SIRT, MNTA, ALNY), COO Robert Forrester, and Lead Director Henri Termeer (former Genzyme Chairman/CEO.) 

The Corporate Forum is delighted to introduce iBio (NYSE MKT: IBIO) to a retail investor audience in Boston.

I am a new fan of The Voice. I love the premise that first a singer has to impress the judges with voice only.  Only when the judges have screened the singer by voice, do other criteria come into play for an overall assessment. What is the singer’s repertoire, style, future promise?  

In partnership with Arrowhead Business Investment and Decisions, the Corporate Forum is delighted to have MIKOH Corporation present to a retail investor audience in Washington, DC on Friday, February 24.

There are many differences between retail and institutional investors – different motivations, resources, pressures and parameters.  However, there is one similarity that is very, very important for companies engaging in outreach.  The clock.  Whether it is a group luncheon with retail investors or a one-on-one with a Fidelity portfolio manager, do not go over your allotted time.

Isn’t it interesting that so many of the recent Noble prize winners for economics are those involved in the field of behavioral economics? This, of course, is the field that says that humans aren’t so rational after all. That we don’t always make decisions based strictly on reason.  In the investing realm, there are often other factors at plan including loss aversion, mental accounting and cost basis anchoring.  

If you’re in the investment business, undoubtedly you’ve sat through your share of investor relations presentations.  Whether you’re a retail broker, member of an investment club or professional investor, you know the format – business review, strategic plan and financial execution.  To keep the presentations from conflating into one big bio-techno-fino-energy story, here are tips to get the most out of a non-deal roadshow.